PTGS2 and ischemic stroke: Furthermore, miRNA-22 has been shown to reduce inflammatory damage caused by ischemic stroke by inhibiting the p38 MAPK/NF-κB pathway, thereby suppressing the expression of inflammatory factors such as PGE2, COX-2 and iNOS [62].